Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 33 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

13%

4 of 31 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

32Total
Not Applicable (14)
P 1 (17)
P 2 (1)

Trial Status

Completed31
Unknown1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 31 completed trials

Clinical Trials (33)

Showing 20 of 20 trials
NCT06397144Phase 1WithdrawnPrimary

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

NCT06774911Not ApplicableCompletedPrimary

Evaluation of Amino Acids Bioavailability in a Food Product Based on a Vegetable Protein Combination

NCT03886766Not ApplicableCompletedPrimary

Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions

NCT06137703Phase 1CompletedPrimary

A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers

NCT05525910Phase 1CompletedPrimary

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

NCT06289140Not ApplicableCompletedPrimary

Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2)

NCT05544786Phase 1CompletedPrimary

Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.

NCT05561075Not ApplicableCompletedPrimary

Oral Bioavailability of Pterostilbene Cocrystal Compared to Its Free Form (BIOPTERO)

NCT05116982Not ApplicableCompleted

Effect of Three Silicon Based Food Supplements on the Urinary Excretion of Aluminum and Other Metals (SILIAL)

NCT05439408Phase 1CompletedPrimary

Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subjects Under Fasting Conditions

NCT05121506Phase 1CompletedPrimary

A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults

NCT03984916Not ApplicableCompletedPrimary

Study of the Bioavailability of Three Hesperidin Extracts.

NCT03951025Phase 2CompletedPrimary

Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN)

NCT04876261Not ApplicableCompletedPrimary

Bioavailability of Hydroxytyrosol From Olive Watery Extract Supplements

NCT02847117Not ApplicableCompletedPrimary

Bioavailability of the Microconstituents of Natural Chios Mastiha in Healthy Adults.

NCT04922996UnknownPrimary

Bioavailability and Pharmacokinetics of Calcium Dobesilate (Doxium®) in the Nasal Mucosal Tissue, Saliva and Blood of Treated Patients

NCT04744233Not ApplicableCompletedPrimary

Bioavailability of Carotenoids From Orange Juice in a Cross-over Study in Healthy Subjects.

NCT03353857Phase 1CompletedPrimary

Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam

NCT04207372Not ApplicableCompletedPrimary

Protein Digestibility of Whey and Zein.

NCT03773068Phase 1CompletedPrimary

A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein

Scroll to load more

Research Network

Activity Timeline